Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Total-body Glucose Utilization in Obesity
NCT06739473Phase 4Recruiting
- Sponsor
- Turku University Hospital
- Start
- Jan 2023
- Primary completion
- Dec 2024
- Countries
- 1
01
Overview
Phase 4, open-label trial (2 arms), sponsored by Turku University Hospital. Primary endpoint: Insulin-induced change in tissue blood flow. Started Jan 2023; status: recruiting.
Beyond the preview
Go deeper on NCT06739473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06739473.